Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-kappaB ligand: the Tromsø Study (Q84453968)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19701599%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-kappaB ligand: the Tromsø Study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19701599%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

6

E Mathiesen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19701599%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

L Jørgensen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19701599%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

A Vik

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19701599%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

N Emaus

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19701599%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

J Brox

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19701599%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

J-B Hansen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19701599%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

P Vestergaard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19701599%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

22 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19701599%20AND%20SRC:MED&resulttype=core&format=json

Osteoporosis International

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19701599%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19701599%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

931-938

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19701599%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19701599%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00198-009-1035-6

6 February 2020

exact match

0 references

cites work

Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure

1 reference

12 December 2020

Circulating amounts of osteoprotegerin and RANK ligand: Genetic influence and relationship with BMD assessed in female twins

1 reference

12 December 2020

Bone resorption by osteoclasts

1 reference

12 December 2020

The relationship between circulating osteoprotegerin levels and bone mineral metabolism in healthy women.

1 reference

12 December 2020

Minireview: the OPG/RANKL/RANK system

1 reference

12 December 2020

The effect of a single dose of osteoprotegerin in postmenopausal women

1 reference

12 December 2020

Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women

1 reference

12 December 2020

Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women

1 reference

12 December 2020

CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications

1 reference

12 December 2020

Increased plasma osteoprotegerin concentrations are associated with indices of bone strength of the hip.

1 reference

12 December 2020

Circulating profiles of osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand in post-menopausal women

1 reference

12 December 2020

Correlates of osteoprotegerin levels in women and men.

1 reference

12 December 2020

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

1 reference

12 December 2020

Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis

1 reference

12 December 2020

The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone

1 reference

12 December 2020

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

12 December 2020

Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women

1 reference

12 December 2020

Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system are associated with bone metabolism in middle-aged males

1 reference

12 December 2020

Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover.

1 reference

12 December 2020

Bone mineral density measures in longitudinal studies: the choice of phantom is crucial for quality assessment. The Tromsø study, a population-based study.

1 reference

12 December 2020

The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappaB legend with bone mineral density in older adults: the Rancho Bernardo study

1 reference

12 December 2020

The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women

1 reference

12 December 2020

Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis

1 reference

12 December 2020

Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status

1 reference

12 December 2020

Serum levels of osteoprotegerin increase with age in a healthy adult population

1 reference

12 December 2020

Serum osteoprotegerin (OPG) and the A163G polymorphism in the OPG promoter region are related to peripheral measures of bone mass and fracture odds ratios.

1 reference

12 December 2020

1 reference

12 December 2020

Denosumab in postmenopausal women with low bone mineral density

1 reference

12 December 2020

Relationships between the changes of serum levels of OPG and RANKL with age, menopause, bone biochemical markers and bone mineral density in Chinese women aged 20-75

1 reference

12 December 2020

The Tromsø study: determinants of precision in bone densitometry

1 reference

12 December 2020

Carotid Plaque Echogenicity and Risk of Nonvertebral Fractures in Women: A Longitudinal Population-Based Study

1 reference

12 December 2020

Soluble RANKL and risk of nontraumatic fracture

1 reference

12 December 2020

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

12 December 2020

The Tromsø Study: artifacts in forearm bone densitometry--prevalence and effect

1 reference

12 December 2020

10.1007/S00198-009-1035-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19701599%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference